
Snigdha Maewall
Examiner (ID: 11665, Phone: (571)272-6197 , Office: P/1612 )
| Most Active Art Unit | 1612 |
| Art Unit(s) | 1612, 1615 |
| Total Applications | 1270 |
| Issued Applications | 627 |
| Pending Applications | 146 |
| Abandoned Applications | 534 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 12117355
[patent_doc_number] => 20180000941
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2018-01-04
[patent_title] => 'PEPTIDE SYSTEMS AND METHODS FOR METABOLIC CONDITIONS'
[patent_app_type] => utility
[patent_app_number] => 15/427164
[patent_app_country] => US
[patent_app_date] => 2017-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 21330
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15427164
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/427164 | Peptide systems and methods for metabolic conditions | Feb 7, 2017 | Issued |
Array
(
[id] => 13867221
[patent_doc_number] => 20190029951
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-31
[patent_title] => EXTENDED RELEASE FORMULATIONS OF VELIPARIB FOR THE TREATMENT OF CANCER
[patent_app_type] => utility
[patent_app_number] => 16/073042
[patent_app_country] => US
[patent_app_date] => 2017-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4312
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16073042
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/073042 | EXTENDED RELEASE FORMULATIONS OF VELIPARIB FOR THE TREATMENT OF CANCER | Jan 30, 2017 | Abandoned |
Array
(
[id] => 11617525
[patent_doc_number] => 20170127712
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-11
[patent_title] => 'DIETARY SUPPLEMENT COMPOSITIONS WITH ENHANCED DELIVERY MATRIX, GUMMIES, CHOCOLATES, ATOMIZERS AND POWDERS CONTAINING SAME, AND METHODS OF MAKING SAME'
[patent_app_type] => utility
[patent_app_number] => 15/414877
[patent_app_country] => US
[patent_app_date] => 2017-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 16959
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15414877
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/414877 | Dietary supplement compositions with enhanced delivery matrix, gummies, chocolates, atomizers and powders containing same, and methods of making same | Jan 24, 2017 | Issued |
Array
(
[id] => 11742710
[patent_doc_number] => 20170196782
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-13
[patent_title] => 'TREATMENT OF SKIN, INCLUDING AGING SKIN, TO IMPROVE APPEARANCE'
[patent_app_type] => utility
[patent_app_number] => 15/412123
[patent_app_country] => US
[patent_app_date] => 2017-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 19442
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15412123
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/412123 | Treatment of skin, including aging skin, to improve appearance | Jan 22, 2017 | Issued |
Array
(
[id] => 12226569
[patent_doc_number] => 09913793
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-03-13
[patent_title] => 'Treatment of skin, including aging skin, to improve appearance'
[patent_app_type] => utility
[patent_app_number] => 15/412232
[patent_app_country] => US
[patent_app_date] => 2017-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 21328
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15412232
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/412232 | Treatment of skin, including aging skin, to improve appearance | Jan 22, 2017 | Issued |
Array
(
[id] => 11742861
[patent_doc_number] => 20170196934
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-13
[patent_title] => 'ORAL PHARMACEUTICAL COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 15/410448
[patent_app_country] => US
[patent_app_date] => 2017-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 25059
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15410448
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/410448 | Oral pharmaceutical composition | Jan 18, 2017 | Issued |
Array
(
[id] => 12924808
[patent_doc_number] => 09827316
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-11-28
[patent_title] => Cardiovascular disease treatment and prevention
[patent_app_type] => utility
[patent_app_number] => 15/409857
[patent_app_country] => US
[patent_app_date] => 2017-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 21578
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15409857
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/409857 | Cardiovascular disease treatment and prevention | Jan 18, 2017 | Issued |
Array
(
[id] => 11602497
[patent_doc_number] => 20170119797
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-04
[patent_title] => 'XYLITOL CONTAINING COMESTIBLE PRODUCT'
[patent_app_type] => utility
[patent_app_number] => 15/407384
[patent_app_country] => US
[patent_app_date] => 2017-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 12437
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15407384
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/407384 | XYLITOL CONTAINING COMESTIBLE PRODUCT | Jan 16, 2017 | Abandoned |
Array
(
[id] => 11668395
[patent_doc_number] => 20170157115
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-08
[patent_title] => 'PHARMACEUTICAL FORMULATION CONTAINING OPIOID AGONIST, OPIOID ANTAGONIST AND GELLING AGENT'
[patent_app_type] => utility
[patent_app_number] => 15/384229
[patent_app_country] => US
[patent_app_date] => 2016-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23356
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15384229
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/384229 | Pharmaceutical formulation containing opioid agonist, opioid antagonist and gelling agent | Dec 18, 2016 | Issued |
Array
(
[id] => 11541836
[patent_doc_number] => 20170095661
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-06
[patent_title] => 'Remineralisation of Calcified Tissue'
[patent_app_type] => utility
[patent_app_number] => 15/382399
[patent_app_country] => US
[patent_app_date] => 2016-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3998
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15382399
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/382399 | Remineralisation of calcified tissue | Dec 15, 2016 | Issued |
Array
(
[id] => 13729361
[patent_doc_number] => 20180369148
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-27
[patent_title] => ABUSE DETERRENT PHARMACEUTICAL DOSAGE FORMS
[patent_app_type] => utility
[patent_app_number] => 16/062122
[patent_app_country] => US
[patent_app_date] => 2016-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5733
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16062122
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/062122 | ABUSE DETERRENT PHARMACEUTICAL DOSAGE FORMS | Dec 15, 2016 | Abandoned |
Array
(
[id] => 13586083
[patent_doc_number] => 20180344590
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-06
[patent_title] => CONTROL OF EVAPORATION OF EMULSIONS STABILIZED WITH LIGNIN
[patent_app_type] => utility
[patent_app_number] => 15/779842
[patent_app_country] => US
[patent_app_date] => 2016-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6940
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15779842
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/779842 | CONTROL OF EVAPORATION OF EMULSIONS STABILIZED WITH LIGNIN | Nov 27, 2016 | Abandoned |
Array
(
[id] => 13603779
[patent_doc_number] => 20180353438
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-13
[patent_title] => EXOTHERMIC TOPICAL DEVICES FOR DELIVERING PHARMACEUTICALS AND COSMETICS TO THE SKIN
[patent_app_type] => utility
[patent_app_number] => 15/780092
[patent_app_country] => US
[patent_app_date] => 2016-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14204
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15780092
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/780092 | EXOTHERMIC TOPICAL DEVICES FOR DELIVERING PHARMACEUTICALS AND COSMETICS TO THE SKIN | Nov 24, 2016 | Abandoned |
Array
(
[id] => 11497648
[patent_doc_number] => 20170071833
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-16
[patent_title] => 'HYDROGEL COMPOSITIONS FOR TOOTH WHITENING'
[patent_app_type] => utility
[patent_app_number] => 15/360938
[patent_app_country] => US
[patent_app_date] => 2016-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14658
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15360938
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/360938 | Hydrogel compositions for tooth whitening | Nov 22, 2016 | Issued |
Array
(
[id] => 16548500
[patent_doc_number] => 10881637
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-01-05
[patent_title] => Intranasal and transdermal administration of kappa-opioid-receptor agonists: salvinorin A for the treatment of neuropsychiatric and addictive disorders
[patent_app_type] => utility
[patent_app_number] => 15/354078
[patent_app_country] => US
[patent_app_date] => 2016-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8774
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15354078
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/354078 | Intranasal and transdermal administration of kappa-opioid-receptor agonists: salvinorin A for the treatment of neuropsychiatric and addictive disorders | Nov 16, 2016 | Issued |
Array
(
[id] => 13586195
[patent_doc_number] => 20180344646
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-06
[patent_title] => AMORPHOUS DISPERSION GRANULES AND ORAL DOSAGE FORMS
[patent_app_type] => utility
[patent_app_number] => 15/778322
[patent_app_country] => US
[patent_app_date] => 2016-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7571
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15778322
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/778322 | AMORPHOUS DISPERSION GRANULES AND ORAL DOSAGE FORMS | Nov 13, 2016 | Abandoned |
Array
(
[id] => 11857876
[patent_doc_number] => 09737543
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-08-22
[patent_title] => 'Treatment of erectile dysfunction and other indications'
[patent_app_type] => utility
[patent_app_number] => 15/342309
[patent_app_country] => US
[patent_app_date] => 2016-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13494
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15342309
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/342309 | Treatment of erectile dysfunction and other indications | Nov 2, 2016 | Issued |
Array
(
[id] => 11567294
[patent_doc_number] => 20170105938
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-20
[patent_title] => 'COMPOSITIONS AND METHODS FOR DELIVERY OF OMEPRAZOLE PLUS ACETYLSALICYLIC ACID'
[patent_app_type] => utility
[patent_app_number] => 15/338825
[patent_app_country] => US
[patent_app_date] => 2016-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 34302
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15338825
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/338825 | Compositions and methods for delivery of omeprazole plus acetylsalicylic acid | Oct 30, 2016 | Issued |
Array
(
[id] => 14806177
[patent_doc_number] => 20190269698
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-05
[patent_title] => PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/343642
[patent_app_country] => US
[patent_app_date] => 2016-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14735
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16343642
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/343642 | Pharmaceutical compositions and uses thereof | Oct 27, 2016 | Issued |
Array
(
[id] => 11441756
[patent_doc_number] => 20170042777
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-16
[patent_title] => 'DENTIFRICE CONTAINING ZINC IONS AND POLYPHOSPHATE IONS'
[patent_app_type] => utility
[patent_app_number] => 15/337226
[patent_app_country] => US
[patent_app_date] => 2016-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1840
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15337226
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/337226 | Dentifrice containing zinc ions and polyphosphate ions | Oct 27, 2016 | Issued |